SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

GWA GWA Group Limited

Industrials · Building Products & Equipment · website
$1.98
52wk 1.94 – 2.74
Overall
58.7
Value
77.1
Growth
45.9
Health
67.2
Quality
77.1
Momentum
14.1
Dividend
70.3
Price
About GWA Group Limited

GWA Group Limited research, designs, imports, and markets building fixtures and fittings to residential and commercial premises in Australia, New Zealand, the United Kingdom, and internationally. It provides sanitaryware, tapware and showers, baths, intelligent water management solutions, and related kitchen, bathroom, and laundry products/accessories under the Caroma, Methven, Clark, and Dorf brands. The company also distributes, installs, maintains, and repairs various products through a range of distribution and customer channels. GWA Group Limited was incorporated in 1992 and is headquartered in Pinkenba, Australia.

Price analytics

Returns

1 day 0.0%
1 week 0.3%
1 month -2.7%
3 months -14.9%
6 months -7.7%
1 year -21.6%
3 years 11.9%

Risk

Volatility (1y ann.) 26.5%
Beta vs ASX 200 0.73
Sharpe (1y) -0.93
VaR 95% (1-day) -2.7%
Max drawdown (1y) -27.8%
Off 1-year high -26.9%

Technicals

RSI(14) 56
vs 50DMA -7.7%
vs 200DMA -12.7%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 77.1
Trailing P/E
91
Forward P/E
94
PEG ratio
21
EV / EBITDA
75
Price / Book
87
Price / Sales
96
Growth 45.9
Revenue growth (1y)
30
Revenue CAGR (3y)
—
EPS growth (1y)
66
EPS CAGR (3y)
41
Financial Health 67.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
61
Debt / Equity
72
Quality (Profitability & Cash Flow) 77.1
Return on equity
81
Return on assets
75
Operating margin
75
Net margin
76
Cash conversion (OCF / net income)
—
Dividend / Income 70.3
Dividend yield (%)
100
Payout ratio
41
FCF dividend cover
—
Momentum 14.1
6-month return vs ASX 200
28
Price vs 200-day average
8
Price vs 50-day average
11
Position in 52-week range
4

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$502.41M
P/E (trailing)
10.97
P/E (forward)
9.67
EPS (trailing)
0.18
Dividend yield
8.6%
Payout ratio
87.4%
Beta
0.75
EV / EBITDA
8.00
Price / Book
1.76
ROE
16.3%
Operating margin
18.8%
Net margin
11.4%
Total cash
$46.42M
Total debt
$201.51M
Current ratio
1.84
Debt / Equity
0.70
Free cash flow
$25.42M
Avg volume
404,861
Latest annual results (FY ending 30 Jun 2026)
  • Revenue—
  • Gross profit—
  • Operating income—
  • Net income—
  • Diluted EPS0.18
  • Free cash flow—
  • Net debt—
Sector peers (Industrials)
TickerMkt cap P/EScore
TCL $40.91B 109.2 29.1
BXB $25.26B 19.0 54.6
QAN $13.30B 10.5 48.5
AIA $11.49B 42.3 39.0
IFT $11.18B 50.9 36.5
ALQ $10.64B 33.3 52.8
REH $10.30B 33.5 49.3
QUB $9.12B 42.6 37.9